Safety and Efficacy of Anti-B-cell Maturation Antigen (Anti-BCMA) Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma: A Systematic Review of Clinical Trials.
Saved in:
| Title: | Safety and Efficacy of Anti-B-cell Maturation Antigen (Anti-BCMA) Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma: A Systematic Review of Clinical Trials. |
|---|---|
| Authors: | Khan AA; Internal Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, GBR., Rahman M; Internal Medicine, Hamilton Medical Center, Dalton, USA.; Internal Medicine, Khyber Medical College, Peshawar, Peshawar, PAK., Jawed I; Dermatology, Dow University of Health Sciences, Karachi, PAK., Sajjad M; Internal Medicine, Hayatabad Medical Complex Peshawar, Peshawar, PAK., Khan MM; Acute and General Medicine, Good Hope Hospital, Birmingham, GBR. |
| Source: | Cureus [Cureus] 2025 Dec 03; Vol. 17 (12), pp. e98368. Date of Electronic Publication: 2025 Dec 03 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-8184 |
|---|---|
| DOI: | 10.7759/cureus.98368 |
